Acumen Pharmaceuticals Inc (ABOS)

NASDAQ
6.32
+0.13(+2.10%)
After Hours
6.01
-0.31(-4.91%)
- Real-time Data
  • Volume:
    137,766
  • Day's Range:
    5.93 - 6.61
  • 52 wk Range:
    3.02 - 10.95

ABOS Overview

Prev. Close
6.19
Day's Range
5.93-6.61
Revenue
-
Open
6.19
52 wk Range
3.02-10.95
EPS
-0.946
Volume
137,766
Market Cap
258.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,385,489
P/E Ratio
-6.43
Beta
0.136
1-Year Change
-23.58%
Shares Outstanding
40,925,284
Next Earnings Date
Mar 27, 2023
What is your sentiment on Acumen Pharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Acumen Pharmaceuticals Inc News

Acumen Pharmaceuticals Inc Company Profile

Acumen Pharmaceuticals Inc Company Profile

Employees
16

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer’s disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Read More

Analyst Price Target

Average15.83 (+150.53% Upside)
High22
Low9
Price6.32
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuySellSell
Technical IndicatorsStrong SellNeutralStrong BuySellSell
SummaryNeutralNeutralStrong BuySellSell
  • A nice sleeper. Get in before fda annoucements!!!!
    0
    • Dear Irmao Alvaro do you know something is it worh to entry and please why ?
      0